Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.3.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JQ.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.502NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.285NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.582NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.580NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.306NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.280NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.329NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.396NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.311NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.369NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.367NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.240NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.192NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ME.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used